Beijing Sl Pharmaceutical Co.,Ltd.’s Net Profit Rose 43.1% in First Three Quarters of 2021
Beijing Sl Pharmaceutical Co.,Ltd. (北京双鹭药业股份有限公司) (002038.SZ) reported a net profit of 432.6 million yuan in the first three quarters of 2021, up 43.1% year-on-year.
Meanwhile, the company posted 913.4 million yuan in revenue, up 8.4% year-on-year.
At the end of the reporting period, it had 5.7 billion yuan in total assets and 411.2 million yuan in total liabilities, with a liability-to-asset ratio of 7.2%.
This article was automatically produced by Caixin Automation on Nov. 3, 2021.
Download our app to receive breaking news alerts and read the news on the go.
Follow the Chinese markets in real time with Caixin Global’s new stock database.
- MOST POPULAR